The Johns Hopkins University School of Medicine Invites You to Attend a Dinner Symposium:
Park Hyatt Chicago
800 North Michigan Avenue
Chicago, IL 60611
Earn Up to 1.5 AMA PRA Category 1 Credits™ at No Charge
|
Presented by The Johns Hopkins University School of Medicine.
Supported by an educational grant from Eli Lilly and Company.
|
Why You Shouldn’t Miss This Educational Program
Lung cancer remains the leading cause of cancer-related deaths worldwide. The World Health Organization estimates that lung cancer is responsible for 1.3 million deaths per year, accounting for 17% of all cancer deaths across the globe.1 In the US, lung cancer continues to be the principal cause of cancer-related deaths in both men and women, with 2007 estimates predicting 213,380 new lung cancer cases to be diagnosed and 160,390 deaths from this disease.2 Despite advances in therapy, only 15% of lung cancer patients survive beyond 5 years from diagnosis.3 In recent years, a decrease in lung cancer incidence and mortality has been seen in the US, led primarily by a declining incidence rate in men, and has been linked to drop in smoking rates over the last several decades.2,4
These activities will begin with an overview of non-small cell lung cancer. The faculty will then provide information on the use of patient histology and developing treatment plans for the individual patient. The activity will continue with a discussion of ways to determine appropriate duration of chemotherapy. Identifying patients who will benefit from the combination of chemotherapeutic agents and targeted agents will be discussed. This activity will also include discussion of emerging clinical data in the treatment of non-small cell lung cancer. An interactive question and answer session will conclude the live activity.
Register now for this practical update!
|
Program Agenda
| 6:30-7:00 PM | Dinner and Registration |
| | |
| 7:00-7:05 PM | Welcome and Overview |
| | |
| 7:05-7:30 PM | New Insights in the Use of Chemotherapy in Specific Histological Subtypes of NSCLC: Is this Progress? |
| | |
| 7:30-7:45 PM | Optimizing Duration of Chemotherapy in NSCLC |
| | |
| 7:45-8:15 PM | Combining Chemotherapy with Biologically Targeted Agents in Advanced NSCLC |
| | |
| 8:15-8:30 PM | Question and Answer Session |
This schedule is subject to change.
|
Accreditation Statement
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
|
Credit Designation Statement
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
|
Objectives
- Determine appropriate duration of chemotherapy to improve patient quality of life.
- Develop individualized treatment plans based on patient histology to improve prognosis.
- Identify those patients most likely to benefit from combination chemotherapy and targeted therapies to improve patient response rate and survival.
- Summarize emerging clinical trial data on combination therapies for non-small cell lung cancer.
The Johns Hopkins University School of Medicine takes responsibility for the content, quality and scientific integrity of this CME program.
|
Presented By
Program Faculty
David S. Ettinger, MD
Course Director
The Alex Grass Professor of Oncology
Professor of Medicine
Professor of Radiation Oncology and Molecular
Radiation Sciences
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University School of Medicine
Giorgio V. Scagliotti, MD, PhD
Thoracic Oncology Unit
Department of Clinical & Biological Sciences
University of Turin
Turino, Italy
Mark A. Socinski, MD
Associate Professor of Medicine
Multidisciplinary Thoracic Oncology Program
Lineberger Comprehensive Cancer Center
University of North Carolina-Chapel Hill
Alan B. Sandler, MD
Associate Professor of Medicine
Division of Hematology/Oncology
Medical Director, Thoracic Oncology
Vanderbilt University Medical Center
Nashville, Tennessee
|
Who Should Attend
This activity is designed for practicing medical oncologists, pathologists, and other healthcare professionals interested in non-small cell lung cancer clinical trial updates and recent advances in diagnosis and treatment.
|
Statement of Policy on Faculty and Sponsor Disclosure
It is the policy of The Johns Hopkins University School of Medicine that the faculty and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and disclose discussion of unlabeled/unapproved uses of drugs or devices during their presentation. Detailed disclosure will be made in the course handout materials.
The Johns Hopkins University School of Medicine fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs by contacting Marcie Farmer at (800) 930-5421.
|
Not an official event of the 2008 Annual Meeting. Not sponsored or endorsed by ASCO or The ASCO Cancer Foundation.
|
Online Course at CME Credits Online™
Earn Up To 1.5 AMA PRA Category 1 Credits™
Take advantage of 24/7 access to valuable educational content and learn at your pace and schedule.
AVAILABLE SUMMER 2008
Mark YES on the registration page to be notified of course availability!
|
CME Audiobook™
Earn Up To 1.5 AMA PRA Category 1 Credits™
Enjoy mobile audio education on a new platform! CME AudioBook™ is an on-the-go solution for busy professionals. Expand your knowledge and stay a breast of important NSCLC educational initiatives. Certified educational content is pre-loaded in a ready-to-go player. Accompanying guide contains syllabus content and player instructions.
AVAILABLE SUMMER 2008
Reserve your player today!
Mark YES on the registration card to automatically receive your FREE CME AudioBook™!
|
To Register for the Non-Small Cell Lung Carcinoma: Clinical Trial Updates and Recent Advances in Diagnosis and Treatment program:
Click Here
Or
Call (866) 531-4826
24 Hours a Day, 7 Days a Week
|
- World Health Organization (WHO) Cancer Factsheet No. 297; February 2006. Available at www.who.int/mediacentre/factsheets/fs297/en/index.html. Accessed December 10, 2007.
- American Cancer Society. Cancer Facts & Figures 2007. Atlanta: American Cancer Society, 2007.
- NCCN Clinical Practice Guidelines in Oncology. Non-Small Cell Lung Cancer, V.2.2008. Available at www.nccn.org/professionals/physician_gls/PDF/ncsl.pdf. Accessed December 10, 2007.
- Ozols RF, Herbst RS, Colson YL, et al. Clinical cancer advances 2006: Major research advances in cancer treatment, prevention, and screening – a report from the American Society of Clinical Oncology. J Clin Oncol. 25:146-162, 2007.
|